Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The microbial cytoplasmic membrane lipid bilayer is a vital structural and functional barrier that encloses the cytoplasm of bacteria and fungi, maintaining the internal environment necessary for life [4]. It consists of a complex arrangement of phospholipids, such as phosphatidylglycerol and phosphatidylethanolamine, and embedded proteins that facilitate nutrient transport, signal transduction, and energy production through the electron transport chain [4]. In pathogens, this membrane is essential for maintaining the proton motive force required for ATP synthesis and for coordinating the assembly of the cell wall [1]. Because microbial membranes often possess a higher net negative charge compared to eukaryotic membranes, they serve as a selective target for various classes of antibiotics, including lipopeptides and polymyxins [1][2]. Therapeutic intervention typically involves the disruption of membrane potential or physical perforation, which leads to rapid bactericidal or fungicidal effects [3][5]. Understanding the unique lipid composition of these membranes is crucial for developing agents that can overcome multidrug-resistant infections while minimizing toxicity to host cells [2].
The primary mechanisms of action for drugs targeting the microbial cytoplasmic membrane include: 1) Pore formation and physical disruption of the lipid bilayer, leading to the leakage of cytoplasmic contents [1][2]; 2) Rapid depolarization of the membrane potential, which halts essential processes like ATP synthesis and nutrient transport [1][4]; 3) Binding to specific lipid components, such as ergosterol in fungi or lipid II in bacteria, to inhibit cell wall synthesis or cause structural failure [3]; and 4) Induction of oxidative stress and secondary metabolic disturbances following membrane damage [2].
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial cytoplasmic membrane lipid bilayer.